AB128868

Anti-SF3A1 抗体 [EPR7666]

Anti-SF3A1 antibody [EPR7666]

RabMAb
Recombinant
了解详情

Be the first to review this product! Submit a review

(2 Publications)

Rabbit Recombinant Monoclonal SF3A1 antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 2 publications.

查看别名

SAP114, SF3A1, Splicing factor 3A subunit 1, SF3a120, Spliceosome-associated protein 114, SAP 114

2 Images

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SF3A1 antibody [EPR7666] (AB128868)

IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SF3A1 antibody [EPR7666] (AB128868)

ab128868 at a 1/50 dilution staining SF3A1 in paraffin embedded Human breast tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Unknown

Western blot - Anti-SF3A1 antibody [EPR7666] (AB128868)

All lanes:

Western blot - Anti-SF3A1 antibody [EPR7666] (ab128868) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 10 µg

Lane 2:

Lymph node lysate at 10 µg

Lane 3:

K562 cell lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 89 kDa

false

不同偶联物与剂型 (1)

Carrier free

Anti-SF3A1 antibody [EPR7666] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR7666

亚型

IgG

不含载体蛋白

反应种属

Human

应用

WB, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style

left-column

style

left-column

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": " Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

style

left-column

产品详情

Patented technology
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production

For more information, read more on recombinant antibodies.

style

left-column

性能和储存信息

形式

Liquid

纯化工艺

Affinity purification Protein A

存储溶液

pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

运输条件

Conditional Ambient

储存信息

Stable for 12 months at -20°C

style

left-column

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The SF3A1 protein also known as SAP114 is a component of the spliceosomal subunit SF3a critical for pre-mRNA splicing. It is approximately 79 kDa in mass. SF3A1 is expressed in various tissues contributing to its broad functional role. The protein is central in assembling the active spliceosome complex facilitating the precise removal of introns from pre-mRNA through exon recognition. This mechanical role is vital for synthesizing mature mRNA molecules necessary for proper gene expression.

Biological function summary

SF3A1 operates as an integral part of the SF3a complex which also consists of SF3A2 and SF3A3. This complex associates with the U2 small nuclear ribonucleoprotein (snRNP) within the spliceosome. The role of SF3A1 in the assembly and stability of this complex is significant ensuring efficient splicing of pre-mRNA. By doing this SF3A1 contributes to the regulation of gene expression by allowing for the generation of multiple mRNA variants from single genes a process known as alternative splicing.

Pathways

SF3A1 plays an important role in the splicing of pre-mRNA an important step in the RNA processing pathway. This pathway ensures that non-coding regions are accurately removed and exons are joined to produce functional mRNA transcripts. SF3A1 works in conjunction with proteins like SF3B1 and U2AF both of which are also spliceosome components. Together these facilitate the selection of splice sites impacting the production of proteins within the cell by influencing mRNA variants that are translated.

SF3A1 alterations have been implicated in myelodysplastic syndromes (MDS) and certain cancers. Mutations or dysregulation of SF3A1 are associated with aberrant splicing patterns contributing to the pathology of these diseases. For instance in MDS SF3A1 mutations may cause ineffective hematopoiesis through improper mRNA processing. SF3A1 interacts with other spliceosomal proteins like U2AF1 where alterations can lead to similar splicing defects that exacerbate disease conditions. Understanding SF3A1's role in such pathologies opens prospects for therapeutic interventions targeting splicing mechanisms.

style

left-column

style

left-column

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

靶点信息

Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed : 10882114, PubMed : 11533230, PubMed : 32494006). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed : 10882114, PubMed : 11533230, PubMed : 32494006). Within the 17S U2 SnRNP complex, SF3A1 is part of the SF3A subcomplex that contributes to the assembly of the 17S U2 snRNP, and the subsequent assembly of the pre-spliceosome 'E' complex and the pre-catalytic spliceosome 'A' complex (PubMed : 10882114, PubMed : 11533230). Involved in pre-mRNA splicing as a component of pre-catalytic spliceosome 'B' complexes (PubMed : 29360106, PubMed : 30315277).

See full target information SF3A1

style

left-column

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Cancer research 78:3190-3206 PubMed29700004

2018

PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Zi Zheng,Meng-Zhu Xue,Hong-Jie Shen,Xiao-Guang Li,Ding Ma,Yue Gong,Yi-Rong Liu,Feng Qiao,Hong-Yan Xie,Bi Lian,Wei-Li Sun,Hai-Yun Zhao,Ling Yao,Wen-Jia Zuo,Da-Qiang Li,Peng Wang,Xin Hu,Zhi-Ming Shao

Molecular biology of the cell 23:4495-505 PubMed23051733

2012

Establishing epithelial glandular polarity: interlinked roles for ARF6, Rac1, and the matrix microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Christine L Monteleon,Alanna Sedgwick,Alyssa Hartsell,Michael Dai,Catherine Whittington,Sherry Voytik-Harbin,Crislyn D'Souza-Schorey

View all publications

style

left-column

style

left-column

style

right-column

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂，为您科研的每一步提供支持。若我们的产品未能达到预期性能，我们向您提供 Abcam Product Promise 保障。

详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

Anti-SF3A1 抗体 [EPR7666]